Schizophrenia.com
Intra-cellular 4th qtr update
News
robertc
March 2, 2020, 2:45pm
1
Intra-cellular 4th quarter update
Caplyta on schedule for release later in March.
2 Likes
Related topics
Topic
Replies
Views
Activity
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
Medications
0
38
November 5, 2024
Intra-cellular Therapies presentation January 15
News
16
531
January 22, 2020
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast
News
0
514
February 22, 2017
Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
News
0
239
February 22, 2021
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
News
6
522
March 23, 2020